Northern Trust Corp Age X Therapeutics, Inc. Transaction History

Northern Trust Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.14 - $1.77 $94 - $146	-83 Reduced 0.26%	31,533 $49,000
Q1 2021 May 12, 2021	BUY	$1.56 - $2.7 $1,171 - $2,027	751 Added 2.43%	31,616 $51,000
Q3 2020 Nov 16, 2020	SELL	$0.79 - $1.52 $273 - $525	-346 Reduced 1.11%	30,865 $25,000
Q2 2020 Aug 14, 2020	SELL	$0.68 - $1.13 $122,533 - $203,622	-180,197 Reduced 85.24%	31,211 $29,000
Q1 2020 May 14, 2020	SELL	$0.78 - $1.95 $7,417 - $18,542	-9,509 Reduced 4.3%	211,408 $197,000
Q4 2019 Feb 14, 2020	SELL	$1.25 - $1.82 $14,621 - $21,288	-11,697 Reduced 5.03%	220,917 $402,000
Q3 2019 Nov 13, 2019	BUY	$1.96 - $3.38 $220,903 - $380,946	112,706 Added 93.99%	232,614 $456,000
Q2 2019 Aug 13, 2019	BUY	$2.58 - $4.92 $30,843 - $58,818	11,955 Added 11.07%	119,908 $441,000
Q1 2019 May 13, 2019	BUY	$3.0 - $4.85 $29,721 - $48,048	9,907 Added 10.1%	107,953 $438,000
Q4 2018 Feb 12, 2019	BUY	$2.49 - $5.5 $244,134 - $539,253	98,046 New	98,046 $293,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.